{
    "nctId": "NCT03732339",
    "briefTitle": "CTC in Predicting Neoadjuvant Chemotherapy Among LABC Patients: a Single-center, Prospective, Exploratory Clinical Trial",
    "officialTitle": "Predictive Value of Circulating Tumor Cells in Neoadjuvant Chemotherapy Among Locally Advanced Breast Cancer Patients: a Single-center, Prospective, Exploratory Clinical Trial",
    "overallStatus": "COMPLETED",
    "conditions": "Locally Advanced Breast Cancer, Circulating Tumor Cell",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 29,
    "primaryOutcomeMeasure": "Predictive value of CTC in ypT0 ypN0",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Patients with histologically confirmed primary invasive breast adenocarcinoma, anatomic stage T2-4N0-3M0 or T1N1-3M0 before neoadjuvant chemotherapy\n* ECOG 0-1\n* Adequate organ function\n* Consent to undergo CTC analysis in vivo\n\nExclusion Criteria:\n\n* Pregnant or breastfeeding patients\n* Metastatic or recurrent patients\n* Uncontrollable infection",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}